800
Participants
Start Date
January 6, 2021
Primary Completion Date
January 31, 2029
Study Completion Date
January 31, 2029
PSMA PET/CT guided intensification of therapy
PSMA PET/CT prior to treatment.
Control Arm
Control - Treatment without PSMA PET/CT
BC Cancer Kelowna, Kelowna
BC Cancer Vancouver, Vancouver
CHU de Québec, Québec
Tom Baker Cancer Center, Calgary
Cross Cancer Institute, Edmonton
CHUM, Montreal
Jewish General Hospital, Montreal
Windsor Regional Cancer Centre, Windsor
Cancer Care Manitoba, Winnipeg
Royal Victoria Regional Health Centre, Barrie
St-Joseph's Healthcare, Hamilton
Juravinski Cancer Centre, Hamilton
Grand River Regional Cancer Centre, Kitchener
London Health Sciences Centre, London
Princess Margaret Cancer Centre, Toronto
Hopital de la Cité de la Santé, Laval
Charles Lemoyne Hospital, Montreal
McGill University Health Center, Montreal
CHUS, Sherbrooke
Collaborators (2)
Canadian Cancer Society (CCS)
OTHER
Lantheus Medical Imaging
INDUSTRY
British Columbia Cancer Agency
OTHER
London Health Sciences Centre
OTHER
Princess Margaret Hospital, Canada
OTHER
Tom Baker Cancer Centre
OTHER
McMaster University
OTHER
Institute of Health Economics, Canada
OTHER
Queen's University
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER